Proficio Capital Partners LLC purchased a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 23,714 shares of the company's stock, valued at approximately $464,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. FMR LLC lifted its stake in shares of Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company's stock worth $330,858,000 after acquiring an additional 271,645 shares during the period. Riverbridge Partners LLC raised its holdings in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after purchasing an additional 958,418 shares in the last quarter. Geode Capital Management LLC lifted its position in Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after purchasing an additional 23,178 shares during the period. Franklin Resources Inc. boosted its holdings in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Privia Health Group by 6.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company's stock worth $19,380,000 after purchasing an additional 65,152 shares during the period. 94.48% of the stock is currently owned by hedge funds and other institutional investors.
Privia Health Group Price Performance
PRVA stock traded down $0.64 on Thursday, hitting $23.38. 650,834 shares of the company were exchanged, compared to its average volume of 756,126. The stock has a market capitalization of $2.82 billion, a price-to-earnings ratio of 233.82, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The business's fifty day moving average is $23.29 and its two-hundred day moving average is $20.89. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04.
Analysts Set New Price Targets
PRVA has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a report on Friday, November 29th. Canaccord Genuity Group raised their target price on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Piper Sandler boosted their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an "outperform" rating and a $25.00 price target for the company. Finally, Needham & Company LLC boosted their price objective on shares of Privia Health Group from $25.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of "Buy" and a consensus price target of $26.67.
Check Out Our Latest Report on Privia Health Group
About Privia Health Group
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Articles

Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.